Editorial: Revealing the unconventional mechanisms of mitochondria-targeting drugs in heart-related diseases.
作者信息
Ren Kaidi, Yang Yang
机构信息
Department of Pharmacy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Clinical Systems Biology Laboratories, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
出版信息
Front Pharmacol. 2025 Jan 6;15:1543291. doi: 10.3389/fphar.2024.1543291. eCollection 2024.
Abstract
摘要
相似文献
1
Editorial: Revealing the unconventional mechanisms of mitochondria-targeting drugs in heart-related diseases.社论：揭示线粒体靶向药物在心脏相关疾病中的非常规机制
Front Pharmacol. 2025 Jan 6;15:1543291. doi: 10.3389/fphar.2024.1543291. eCollection 2024.
2
Artificial targeting of autophagy components to mitochondria reveals both conventional and unconventional mitophagy pathways.将自噬成分人工靶向至线粒体揭示了传统和非传统的线粒体自噬途径。
Autophagy. 2025 Feb;21(2):315-337. doi: 10.1080/15548627.2024.2395149. Epub 2024 Sep 8.
3
Mitochondria targeting drugs for neurodegenerative diseases-Design, mechanism and application.用于神经退行性疾病的线粒体靶向药物——设计、作用机制及应用
Acta Pharm Sin B. 2022 Jun;12(6):2778-2789. doi: 10.1016/j.apsb.2022.03.001. Epub 2022 Mar 10.
4
Cilia, mitochondria, and cardiac development.纤毛、线粒体与心脏发育。
J Clin Invest. 2019 Jun 17;129(7):2666-2668. doi: 10.1172/JCI129827.
5
An unconventional pathway for mitochondrial protein degradation.线粒体蛋白降解的一条非常规途径。
Autophagy. 2016 Nov;12(11):1971-1972. doi: 10.1080/15548627.2016.1235127. Epub 2016 Sep 29.
6
Mitochondria-targeted nanomedicines for cardiovascular applications.用于心血管应用的线粒体靶向纳米药物。
Nanomedicine (Lond). 2023 Dec;18(28):2101-2104. doi: 10.2217/nnm-2023-0321. Epub 2023 Dec 7.
7
Identification of a novel toxicophore in anti-cancer chemotherapeutics that targets mitochondrial respiratory complex I.鉴定一种新型的抗癌化疗药物毒力基团，该基团靶向线粒体呼吸复合物 I。
Elife. 2020 May 20;9:e55845. doi: 10.7554/eLife.55845.
8
Effective Agents Targeting the Mitochondria and Apoptosis to Protect the Heart.靶向线粒体和细胞凋亡以保护心脏的有效药物
Curr Pharm Des. 2017;23(8):1153-1166. doi: 10.2174/1381612822666161229150120.
9
Dealing with an Unconventional Genetic Code in Mitochondria: The Biogenesis and Pathogenic Defects of the 5-Formylcytosine Modification in Mitochondrial tRNA.应对线粒体中的非常规遗传密码：线粒体tRNA中5-甲酰基胞嘧啶修饰的生物发生及致病缺陷
Biomolecules. 2017 Mar 2;7(1):24. doi: 10.3390/biom7010024.
10
Emerging insights into mitochondria-specific targeting and drug delivering strategies: Recent milestones and therapeutic implications.线粒体特异性靶向与药物递送策略的新见解：近期进展与治疗意义
Saudi J Biol Sci. 2020 Dec;27(12):3581-3592. doi: 10.1016/j.sjbs.2020.07.030. Epub 2020 Aug 1.
本文引用的文献
1
Mitophagy for cardioprotection.线粒体自噬的心脏保护作用。
Basic Res Cardiol. 2023 Oct 5;118(1):42. doi: 10.1007/s00395-023-01009-x.
2
High-resolution visualization and assessment of basal and OXPHOS-induced mitophagy in H9c2 cardiomyoblasts.高分辨率可视化和评估 H9c2 心肌细胞中的基础和 OXPHOS 诱导的线粒体自噬。
Autophagy. 2023 Oct;19(10):2769-2788. doi: 10.1080/15548627.2023.2230837. Epub 2023 Jul 5.
3
Cardiac lipid metabolism, mitochondrial function, and heart failure.心脏脂质代谢、线粒体功能与心力衰竭。
Cardiovasc Res. 2023 Aug 19;119(10):1905-1914. doi: 10.1093/cvr/cvad100.
4
Mitochondrial Dysfunction and Therapeutic Perspectives in Cardiovascular Diseases.线粒体功能障碍与心血管疾病的治疗策略
Int J Mol Sci. 2022 Dec 16;23(24):16053. doi: 10.3390/ijms232416053.
5
Mitophagy in cardiovascular diseases: molecular mechanisms, pathogenesis, and treatment.细胞自噬在心血管疾病中的作用：分子机制、发病机制和治疗。
Trends Mol Med. 2022 Oct;28(10):836-849. doi: 10.1016/j.molmed.2022.06.007. Epub 2022 Jul 22.
6
Ketone therapy for heart failure: current evidence for clinical use.酮疗法治疗心力衰竭：临床应用的当前证据
Cardiovasc Res. 2022 Mar 16;118(4):977-987. doi: 10.1093/cvr/cvab068.
7
Mitochondria as a therapeutic target for ischemic stroke.线粒体作为缺血性中风的治疗靶点。
Free Radic Biol Med. 2020 Jan;146:45-58. doi: 10.1016/j.freeradbiomed.2019.11.005. Epub 2019 Nov 5.
Zotero 插件